Stay updated with breaking news from Peter Griffith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Michael Caine was recently seen on the red carpet for the first time in over two years for the London premiere of his new movie, "The Great Escaper."
Horrified to learn I've been spending money on contact lenses when all I really needed was a small tube of very expensive essential oils.
By Deena Beasley (Reuters) - Amgen, which is facing U.S. Federal Trade Commission (FTC) delays to its planned acquisition of Horizon Therapeutics, on ...
The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects a deal to acquire Horizon Therapeutics to close by mid-December.
(Reuters) -Amgen, which is facing U.S. Federal Trade Commission (FTC) delays to its planned acquisition of Horizon Therapeutics, on Thursday reported higher quarterly profit on strong sales of treatments for cholesterol, osteoporosis and other drugs. The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects the Horizon deal to close by mid-December. For the second quarter, Amgen reported revenue of $6.99 billion, up 6% from a year earlier, exceeding analysts' estimates of $6.68 billion, according to Refinitiv data.